The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma

Authors: Anna Truini, Jacqueline H. Starrett, Tyler Stewart, Kumar Ashtekar, Zenta Walther, Anna Wurtz, David Lu, Jin H. Park, Michelle DeVeaux, Xiaoling Song, Scott Gettinger, Daniel Zelterman, Mark A. Lemmon, Sarah B. Goldberg, Katerina Politi

Published: 2019-06-10

DOI: 10.1158/1078-0432.ccr-19-0780

Source: Full article

---

Abstract

Abstract